Orange Book product · Generic (ANDA)
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
At a glance
Sep 13, 1985
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 13, 1985
41 yr 4 mo ago
Today
Pharmaceutical detail
Active ingredient
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
Strength
0.005MG/ML;1.5%
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 088571
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
- 2004LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEBrand (NDA)
NDA 021486 · EMPI
- 2004LIDOSITE TOPICAL SYSTEM KITBrand (NDA)
NDA 021504 · VYTERIS
- 1995IONTOCAINEBrand (NDA)
NDA 020530 · IOMED
- —XYLOCAINE DENTAL WITH EPINEPHRINEBrand (NDA)
NDA 021381 · DENTSPLY PHARM
- —XYLOCAINE W/ EPINEPHRINEBrand (NDA)
NDA 010418 · ASTRAZENECA
- —XYLOCAINE W/ EPINEPHRINEBrand (NDA)
NDA 006488 · FRESENIUS KABI USA
- 2021LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 208475 · B BRAUN MEDICAL
- 2008LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 078772 · HOSPIRA
- 1993LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 040057 · EASTMAN KODAK
- 1988LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 089635 · HOSPIRA
- 1988LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 089649 · HOSPIRA
- 1988LIDOCAINE HYDROCHLORIDE AND EPINEPHRINEGeneric (ANDA)
ANDA 089645 · HOSPIRA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
